The Canadian AI Index

Founders / Alexander Mosa

Alexander Mosa

Alexander Mosa is a co-founder of Biossil, a health and biotech AI company based in Toronto. Alexander Mosa co-founded Biossil with Anthony Mouchantaf. Biossil had raised C$309.3M across 4 rounds as of November 2026, most recently a US$153M venture round in September 2026 led by OpenAI Startup Fund. The Canadian AI Newsletter last covered Biossil in September 2026.

Alexander Mosa is a co-founder of Biossil and serves as its Chief Scientific Officer and Chair. The Toronto company uses an AI platform to find drug candidates that stalled before finishing clinical trials, then buys or licenses them to continue development. Mosa co-founded Biossil in 2023 with Anthony Mouchantaf. Mosa holds a doctor of medicine degree and a PhD in virology, trained at the University Health Network, and trained to be an internal medicine specialist before leaving to start the company.

Co-founder of Biossil.

LinkedIn

Suggest a correction

Biossil

AI platform to identify and revive failed late-stage drug candidates.

Role
Co-founder
HQ
Toronto, ON
Founded
2023
Status
Active
Disclosed raised
C$309.3M
Latest round
Venture round, Sep 28, 2026
Website
biossil.co

Co-founders: Anthony Mouchantaf

Investors: OpenAI Startup Fund, Founders Fund, Staircase Ventures, Quiet Capital, Modern Capital, Golden Ventures, Panache Ventures, Duke University endowment, and 1 more

In the newsletter

Founders are listed as named in primary coverage of their companies. Profile links are matched to the company before they are published. To correct this page or ask for it to be removed, email the Index.

Data as of November 10, 2026.

Support the Index by subscribing to the newsletter.

This database updates weekly. Get the update, plus the week's Canadian AI news, by email.

Subscribe on Substack

Opens Substack in a new tab.